Burns JM, Summers BC, Wang Y, Melikian A, Berahovich R, Miao Z, Penfold ME, Sunshine MJ, Littman DR, Kuo CJ, Wei K, McMaster BE, Wright K, Howard MC, Schall TJ: A novel chemokine receptor for SDF-1 and I-TAC involved in cell survival, cell adhesion, and tumor development. J Exp Med. 2006, 203 (9): 2201-2213. 10.1084/jem.20052144
Article
PubMed Central
CAS
PubMed
Google Scholar
Tarnowski M, Grymula K, Liu R, Tarnowska J, Drukala J, Ratajczak J, Mitchell RA, Ratajczak MZ, Kucia M: Macrophage Migration Inhibitory Factor Is Secreted by Rhabdomyosarcoma Cells, Modulates Tumor Metastasis by Binding to CXCR4 and CXCR7 Receptors and Inhibits Recruitment of Cancer-Associated Fibroblasts. Mol Cancer Res. 2010, 8 (10): 1328-1343. 10.1158/1541-7786.MCR-10-0288
Article
PubMed Central
CAS
PubMed
Google Scholar
Balabanian K, Lagane B, Infantino S, Chow KYC, Harriague J, Moepps B, Arenzana-Seisdedos F, Thelen M, Bachelerie F: The chemokine SDF-1/CXCL12 binds to and signals through the orphan receptor RDC1 in T lymphocytes. J Biol Chem. 2005, 280 (42): 35760-35766. 10.1074/jbc.M508234200
Article
CAS
PubMed
Google Scholar
Lagane B, Chow KYC, Balabanian K, Levoye A, Harriague J, Planchenault T, Baleux F, Gunera-Saad N, Arenzana-Seisdedos F, Bachelerie F: CXCR4 dimerization and beta-arrestin-mediated signaling account for the enhanced chemotaxis to CXCL12 in WHIM syndrome. Blood. 2008, 112 (1): 34-44. 10.1182/blood-2007-07-102103
Article
CAS
PubMed
Google Scholar
Boldajipour B, Mahabaleshwar H, Kardash E, Reichman-Fried M, Blaser H, Minina S, Wilson D, Xu QL, Raz E: Control of chemokine-guided cell migration by ligand sequestration. Cell. 2008, 132 (3): 463-473. 10.1016/j.cell.2007.12.034
Article
CAS
PubMed
Google Scholar
Allen SJ, Crown SE, Handel TM: Chemokine: Receptor structure, interactions, and antagonism. Annu Rev Immunol. 2007, 25: 787-820. 10.1146/annurev.immunol.24.021605.090529
Article
CAS
PubMed
Google Scholar
Grodecka M, Wasniowska K: Interceptors:–"silent" chemokine receptors. Postepy Hig Med Dosw (Online). 2007, 61: 231-239.
Google Scholar
Rajagopal S, Kim J, Ahn S, Craig S, Lam CM, Gerard NP, Gerard C, Lefkowitz RJ: Beta-arrestin- but not G protein-mediated signaling by the "decoy" receptor CXCR7. Proc Natl Acad Sci U S A. 2010, 107 (2): 628-632. 10.1073/pnas.0912852107
Article
PubMed Central
PubMed
Google Scholar
Luttrell LM, Roudabush FL, Choy EW, Miller WE, Field ME, Pierce KL, Lefkowitz RJ: Activation and targeting of extracellular signal-regulated kinases by beta-arrestin scaffolds. Proc Natl Acad Sci U S A. 2001, 98 (5): 2449-2454. 10.1073/pnas.041604898
Article
PubMed Central
CAS
PubMed
Google Scholar
Noma T, Lemaire A, Naga Prasad SV, Barki-Harrington L, Tilley DG, Chen J, Le Corvoisier P, Violin JD, Wei H, Lefkowitz RJ, Rockman HA: Beta-arrestin-mediated beta1-adrenergic receptor transactivation of the EGFR confers cardioprotection. J Clin Invest. 2007, 117 (9): 2445-2458. 10.1172/JCI31901
Article
PubMed Central
CAS
PubMed
Google Scholar
Maudsley S, Pierce KL, Zamah AM, Miller WE, Ahn S, Daaka Y, Lefkowitz RJ, Luttrell LM: The beta(2)-adrenergic receptor mediates extracellular signal-regulated kinase activation via assembly of a multi-receptor complex with the epidermal growth factor receptor. J Biol Chem. 2000, 275 (13): 9572-9580. 10.1074/jbc.275.13.9572
Article
CAS
PubMed
Google Scholar
Torossian F, Anginot A, Chabanon A, Clay D, Guerton B, Desterke C, Boutin L, Marullo S, Scott MG, Lataillade JJ, Le Bousse-Kerdilès MC: CXCR7 participates in CXCL12-induced CD34+ cell cycling through β-arrestin-dependent Akt activation. Blood. 2014, 123 (2): 191-202. 10.1182/blood-2013-05-500496
Article
CAS
PubMed
Google Scholar
Miao Z, Luker KE, Summers BC, Berahovich R, Bhojani MS, Rehemtulla A, Kleer CG, Essner JJ, Nasevicius A, Luker GD, Howard MC, Schall TJ: CXCR7 (RDC1) promotes breast and lung tumor growth in vivo and is expressed on tumor-associated vasculature. Proc Natl Acad Sci U S A. 2007, 104: 15735-15740. 10.1073/pnas.0610444104
Article
PubMed Central
CAS
PubMed
Google Scholar
Wang JH, Shiozawa YS, Wang JC, Wang Y, Jung YH, Pienta KJ, Mehra R, Loberg R, Taichman RS: The role of CXCR7/RDC1 as a chemokine receptor for CXCL12/SDF-1 in prostate cancer. J Biol Chem. 2008, 283 (7): 4283-4294. 10.1074/jbc.M707465200
Article
CAS
PubMed
Google Scholar
Singh RK, Lokeshwar BL: The IL-8-regulated chemokine receptor CXCR7 stimulates EGFR signaling to promote prostate cancer growth. Cancer Res. 2011, 71 (9): 3268-3277. 10.1158/0008-5472.CAN-10-2769
Article
PubMed Central
CAS
PubMed
Google Scholar
Van Rechem C, Rood BR, Touka M, Pinte S, Jenal M, Guérardel C, Ramsey K, Monté D, Bégue A, Tschan MP, Stephan DA, Leprince D: Scavenger chemokine (CXC motif) receptor 7 (CXCR7) is a direct target gene of HIC1 (hypermethylated in cancer 1). J Biol Chem. 2009, 284 (31): 20927-20935. 10.1074/jbc.M109.022350
Article
PubMed Central
CAS
PubMed
Google Scholar
Liu H, Xue W, Ge G, Luo X, Li Y, Xiang H, Ding X, Tian P, Tian X: Hypoxic preconditioning advances CXCR4 and CXCR7 expression by activating HIF-1 alpha in MSCs. Biochem Biophys Res Commun. 2010, 401 (4): 509-515. 10.1016/j.bbrc.2010.09.076
Article
CAS
PubMed
Google Scholar
Tarnowski M, Grymula K, Reca R, Jankowski K, Maksym R, Tarnowska J, Przybylski G, Barr FG, Kucia M, Ratajczak MZ: Regulation of expression of stromal-derived factor-1 receptors: CXCR4 and CXCR7 in human rhabdomyosarcomas. Mol Cancer Res. 2010, 8 (1): 1-14. 10.1158/1541-7786.MCR-09-0259
Article
PubMed Central
CAS
PubMed
Google Scholar
Tarnowski M, Liu R, Wysoczynski M, Ratajczak J, Kucia M, Ratajczak MZ: CXCR7: a new SDF-1-binding receptor in contrast to normal CD34(+) progenitors is functional and is expressed at higher level in human malignant hematopoietic cells. Eur J Haematol. 2010, 85 (6): 472-483. 10.1111/j.1600-0609.2010.01531.x
Article
CAS
PubMed
Google Scholar
Maksym RB, Tarnowski M, Grymula K, Tarnowska J, Wysoczynski M, Liu R, Czerny B, Ratajczak J, Kucia M, Ratajczak MZ: The role of stromal-derived factor-1-CXCR7 axis in development and cancer. Eur J Pharmacol. 2009, 625 (1–3): 31-40.
Article
PubMed Central
CAS
PubMed
Google Scholar
Neve RM, Chin K, Fridlyand J, Yeh J, Baehner FL, Fevr T, Clark L, Bayani N, Coppe JP, Tong F, Speed T, Spellman PT, DeVries S, Lapuk A, Wang NJ, Kuo WL, Stilwell JL, Pinkel D, Albertson DG, Waldman FM, McCormick F, Dickson RB, Johnson MD, Lippman M, Ethier S, Gazdar A, Gray JW: A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes. Cancer Cell. 2006, 10 (6): 515-527. 10.1016/j.ccr.2006.10.008
Article
PubMed Central
CAS
PubMed
Google Scholar
Boudot A, Kerdivel G, Habauzit D, Eeckhoute J, Dily L, Samson M, Pakdel F: Differential Estrogen-Regulation of CXCL12 Chemokine Receptors, CXCR4 and CXCR7, Contributes to the Growth Effect of Estrogens in Breast Cancer Cells. PLoS One. 2011, 6 (6): 1-12.
Article
Google Scholar
Ma X-J, Dahiya S, Richardson E, Erlander M, Sgroi DC: Gene expression profiling of the tumor microenvironment during breast cancer progression. Breast Cancer Res. 2009, 11 (1): R7- 10.1186/bcr2222
Article
PubMed Central
PubMed
Google Scholar
Wang Y, Li G, Stanco A, Long JE, Crawford D, Potter GB, Pleasure SJ, Behrens T, Rubenstein JLR: CXCR4 and CXCR7 have distinct functions in regulating interneuron migration. Neuron. 2011, 69 (1): 61-76. 10.1016/j.neuron.2010.12.005
Article
PubMed Central
CAS
PubMed
Google Scholar
Lee E, Han J, Kim K, Choi H, Cho E-G, Lee TR: CXCR7 mediates SDF1-induced melanocyte migration. Pigment Cell Melanoma Res. 2013, 26 (1): 58-66. 10.1111/pcmr.12024
Article
CAS
PubMed
Google Scholar
Puchert M, Engele J: The peculiarities of the SDF-1/CXCL12 system: in some cells, CXCR4 and CXCR7 sing solos, in others, they sing duets. Cell Tissue Res. 2014, 355 (2): 239-253. 10.1007/s00441-013-1747-y
Article
CAS
PubMed
Google Scholar
Clark GM, Sledge GW, Osborne CK, McGuire WL: Survival from first recurrence: relative importance of prognostic factors in 1, 015 breast cancer patients. J Clin Oncol. 1987, 5 (1): 55-61.
CAS
PubMed
Google Scholar
Luker KE, Sa L, La M, Schmidt BT, Winkler JS, Coggins NL, Thomas DG, Luker GD: Scavenging of CXCL12 by CXCR7 promotes tumor growth and metastasis of CXCR4-positive breast cancer cells. Oncogene. 2011, 2012: 1-9.
Google Scholar
Nigam N, Prasad S, George J, Shukla Y: Lupeol induces p53 and cyclin-B-mediated G2/M arrest and targets apoptosis through activation of caspase in mouse skin. Biochem Biophys Res Commun. 2009, 381 (2): 253-258. 10.1016/j.bbrc.2009.02.033
Article
CAS
PubMed
Google Scholar
Luker KE, Gupta M, Luker GD: Bioluminescent CXCL12 fusion protein for cellular studies of CXCR4 and CXCR7. Biotechniques. 2009, 47 (1): 625-632. 10.2144/000113126
Article
PubMed Central
CAS
PubMed
Google Scholar
Luker KE, Steele JM, Mihalko L, Ray P, Luker GD: Constitutive and chemokine-dependent internalization and recycling of CXCR7 in breast cancer cells to degrade chemokine ligands. Oncogene. 2010, 29 (32): 4599-4610.
Article
PubMed Central
CAS
PubMed
Google Scholar
Hernandez L, Magalhaes MO, Coniglio SJ, Condeelis JS, Segall JE: Opposing roles of CXCR4 and CXCR7 in breast cancer metastasis. Breast Cancer Res. 2011, 13 (6): R128-R128. 10.1186/bcr3074
Article
PubMed Central
CAS
PubMed
Google Scholar
Kang H, Watkins G, Parr C, Douglas-Jones A, Mansel RE, Jiang WG: Stromal cell derived factor-1: its influence on invasiveness and migration of breast cancer cells in vitro, and its association with prognosis and survival in human breast cancer. Breast Cancer Res. 2005, 7 (4): R402-R410.
Article
PubMed Central
CAS
PubMed
Google Scholar
Balkwill F: The significance of cancer cell expression of the chemokine receptor CXCR4. Semin Cancer Biol. 2004, 14 (3): 171-179. 10.1016/j.semcancer.2003.10.003
Article
CAS
PubMed
Google Scholar
Müller A, Homey B, Soto H, Ge N, Catron D, Buchanan ME, McClanahan T, Murphy E, Yuan W, Wagner SN, Barrera JL, Mohar A, Verástegui E, Zlotnik A: Involvement of chemokine receptors in breast cancer metastasis. Nature. 2001, 410 (6824): 50-56. 10.1038/35065016
Article
PubMed
Google Scholar
Schrevel M, Karim R, ter Haar NT, van der Burg SH, Trimbos JBMZ, Fleuren GJ, Gorter A, Jordanova ES: CXCR7 expression is associated with disease-free and disease-specific survival in cervical cancer patients. Br J Cancer. 2012, 106 (9): 1520-1525. 10.1038/bjc.2012.110
Article
PubMed Central
CAS
PubMed
Google Scholar
Yates TJ, Knapp J, Gosalbez M, Lokeshwar SD, Gomez CS, Benitez A, Ekwenna OO, Young EE, Manoharan M, Lokeshwar VB: C-X-C chemokine receptor 7: A functionally associated molecular marker for bladder cancer. Cancer. 2013, 119 (1): 61-71. 10.1002/cncr.27661
Article
PubMed Central
CAS
PubMed
Google Scholar
Sánchez-Martín L, Sánchez-Mateos P, Cabañas C: CXCR7 impact on CXCL12 biology and disease. Trends Mol Med. 2013, 19 (1): 12-22. 10.1016/j.molmed.2012.10.004
Article
PubMed
Google Scholar
Levoye A, Balabanian K, Baleux F, Bachelerie F, Lagane B: CXCR7 heterodimerizes with CXCR4 and regulates CXCL12-mediated G protein signaling. Blood. 2009, 113 (24): 6085-6093. 10.1182/blood-2008-12-196618
Article
CAS
PubMed
Google Scholar
Berahovich RD, Zabel BA, Lewen S, Walters MJ, Ebsworth K, Wang Y, Jaen JC, Schall TJ: Endothelial expression of CXCR7 and the regulation of systemic CXCL12 levels. Immunology. 2014, 141 (1): 111-122. 10.1111/imm.12176
Article
PubMed Central
CAS
PubMed
Google Scholar
Chinni SR, Yamarnoto H, Dong Z, Sabbota A, Bonfil RD, Cher ML: CXCL12/CXCR4 transactivates HER2 in lipid rafts of prostate cancer cells and promotes growth of metastatic deposits in bone. Mol Cancer Res. 2008, 6 (3): 446-457. 10.1158/1541-7786.MCR-07-0117
Article
CAS
PubMed
Google Scholar
Azzi M, Charest PG, Angers S, Rousseau G, Kohout T, Bouvier M, Pineyro G: beta-Arrestin-mediated activation of MAPK by inverse agonists reveals distinct active conformations for G protein-coupled receptors. Proc Natl Acad Sci U S A. 2003, 100 (20): 11406-11411. 10.1073/pnas.1936664100
Article
PubMed Central
CAS
PubMed
Google Scholar
Michal AM, Peck AR, Tran TH, Liu C, Rimm DL, Rui H, Benovic JL: Differential expression of arrestins is a predictor of breast cancer progression and survival. Breast Cancer Res Treat. 2011, 130 (3): 791-807. 10.1007/s10549-011-1374-9
Article
PubMed Central
CAS
PubMed
Google Scholar
Salazar N, Munoz D, Hoy J, Lokeshwar BL: Use of shRNA for Stable Suppression of Chemokine Receptor Expression and Function in Human Cancer Cell Lines. Methods Mole Biol. 2014, 1172: 209-218. 10.1007/978-1-4939-0928-5_19.
Article
Google Scholar
Luker KE, Gupta M, Steele JM, Foerster BR, Luker GD: Imaging Ligand-Dependent Activation of CXCR7. Neoplasia. 2009, 11 (10): 1022-1035.
Article
PubMed Central
CAS
PubMed
Google Scholar
Lokeshwar BL, Selzer MG, Zhu BQ, Block NL, Golub LM: Inhibition of cell proliferation, invasion, tumor growth and metastasis by an oral non-antimicrobial tetracycline analog (COL-3) in a metastatic prostate cancer model. Int J Cancer. 2002, 98 (2): 297-309. 10.1002/ijc.10168
Article
CAS
PubMed
Google Scholar
Rhodes DR, Yu JJ, Shanker K, Deshpande N, Varambally R, Ghosh D, Barrette T, Pandey A, Chinnaiyan AM: ONCOMINE: A cancer microarray database and integrated data-mining platform. Neoplasia. 2004, 6 (1): 1-6. 10.1016/S1476-5586(04)80047-2
Article
PubMed Central
CAS
PubMed
Google Scholar